Inventor
LEE WILLIAM A
US44 patents
⚠️ This page may combine multiple inventors who share the name “LEE WILLIAM A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
14 patentsUS6225460B1May 1, 2001
Nucleotide analogs
GILEAD SCIENCES INC132 citations98
US5798340AAug 25, 1998
Nucleotide analogs
GILEAD SCIENCES INC126 citations98
US9139604B2Sep 22, 2015
Antiviral phosphonate analogs
GILEAD SCIENCES INC42 citations97
US8871785B2Oct 28, 2014
Antiviral phosphonate analogs
GILEAD SCIENCES INC49 citations97
US8022083B2Sep 20, 2011
Antiviral phosphonate analogs
GILEAD SCIENCES INC46 citations97
US7645747B2Jan 12, 2010
Therapeutic phosphonate compounds
GILEAD SCIENCES INC60 citations97
US7390791B2Jun 24, 2008
Prodrugs of phosphonate nucleotide analogues
GILEAD SCIENCES INC183 citations96
US5886179AMar 23, 1999
Nucleotide analogs
GILEAD SCIENCES INC60 citations96
US7803788B2Sep 28, 2010
Prodrugs of phosphonate nucoleotide analogues
GILEAD SCIENCES INC96 citations95
US7462608B2Dec 9, 2008
Non nucleoside reverse transcriptase inhibitors
GILEAD SCIENCES INC51 citations95
US7553825B2Jun 30, 2009
Anti-proliferative compounds, compositions, and methods of use thereof
GILEAD SCIENCES INC13 citations92
US7429565B2Sep 30, 2008
Antiviral phosphonate analogs
GILEAD SCIENCES INC25 citations92
US7649015B2Jan 19, 2010
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
GILEAD SCIENCES INC19 citations91
US7439350B2Oct 21, 2008
Nucleotide analogs
GILEAD SCIENCES INC4 citations73
SYNTEX INC
12 patentsUS4753935AJun 28, 1988
Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
SYNTEX INC125 citations97
US4992467AFeb 12, 1991
Treatment of autoimmune diseases with mycophenolic acid, and derivatives and formulations thereof
SYNTEX INC33 citations96
US4952579AAug 28, 1990
Method of treating diseases by administering morpholino-ethylester of mycophenolic acid or derivatives thereof
SYNTEX INC44 citations96
US4948793AAug 14, 1990
Treatment of autoimmune diseases with the morpholinoethyl ester of mycophenolic acid, and derivatives thereof
SYNTEX INC53 citations96
US4868153ASep 19, 1989
Treatment of allograft rejection with mycophenolic acid, its morpholinoethylester and derivatives thereof
SYNTEX INC54 citations96
US4861776AAug 29, 1989
Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
SYNTEX INC56 citations96
US4808592AFeb 28, 1989
Method of treating diseases by administering morpholinoethylester of mycophenolic acid and derivatives thereof
SYNTEX INC52 citations96
US4786637ANov 22, 1988
Treatment of allograft rejection with mycophenolic acid morpholinoethylester and derivatives thereof
SYNTEX INC62 citations96
US4727069AFeb 23, 1988
Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
SYNTEX INC54 citations96
US5376369ADec 27, 1994
Vaccine adjuvant
SYNTEX INC61 citations95
US4748173AMay 31, 1988
Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
SYNTEX INC43 citations92
US5177072AJan 5, 1993
Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
SYNTEX INC5 citations63
MARCOLL INTERNAT CORP
5 patentsUSD570449SJun 3, 2008
Sink fixture
MARCOLL INTERNAT CORP12 citations84
USD570958SJun 10, 2008
Sink fixture
MARCOLL INTERNAT CORP7 citations73
USD578183SOct 7, 2008
Sink fixture
MARCOLL INTERNAT CORP4 citations62
USD570957SJun 10, 2008
Sink fixture
MARCOLL INTERNAT CORP4 citations62
USD570959SJun 10, 2008
Sink fixture
MARCOLL INTERNAT CORP1 citations52